Searched for: in-biosketch:true
person:avikie01
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study [Editorial]
Schleicher, Stephen M; Chaudhry, Basit; Dickson, Natalie R; Aviki, Emeline; Arrowsmith, Edward; Parikh, Ravi B; Yue, Andrew T; Connor, Nora; Schwartzberg, Lee; Lyss, Aaron J
PMID: 33872069
ISSN: 2688-1535
CID: 5521832
Diaphragm hernia after debulking surgery in patients with ovarian cancer [Case Report]
Ehmann, Sarah; Aviki, Emeline M; Sonoda, Yukio; Boerner, Thomas; Sassine, Dib; Jones, David R; Park, Bernard; Cohen, Murray; Rosenblum, Norman G; Chi, Dennis S
Over 80% of patients with epithelial ovarian cancer present with advanced disease, FIGO stage III or IV at the time of diagnosis. The majority require extensive upper abdominal surgery to obtain complete gross resection. This may include splenectomy, distal pancreatectomy, partial hepatectomy, cholecystectomy, and usually diaphragmatic peritonectomy or resection. Following surgery, diaphragmatic hernia-a very rare but serious complication-may occur. We describe four cases of left-sided diaphragmatic hernia resulting after debulking surgery, which included left diaphragm peritonectomy and splenectomy, in patients with advanced ovarian cancer. In association with the current shift towards more extensive debulking surgery for ovarian cancer, more patients may present with postoperative left-sided diaphragm hernia, making the prevention, diagnosis, and management of this complication important to practicing gynecologic oncologists. Intraoperatively the diaphragm should be checked thoroughly to rule out any defects, which should be closed. A diaphragmatic hernia may be easily misdiagnosed because the patient can present with various symptoms. While rare, these hernias require prompt identification, intervention and surgical correction to avoid serious complications.
PMCID:8042427
PMID: 33869713
ISSN: 2352-5789
CID: 5521822
Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer
Luo, Leo Y; Aviki, Emeline M; Lee, Anna; Kollmeier, Marisa A; Abu-Rustum, Nadeem R; Tsai, C Jillian; Alektiar, Kaled M
OBJECTIVE:Gaps in access to appropriate cancer care, and associated cancer mortality, have widened across socioeconomic groups. We examined whether demographic and socioeconomic factors influenced receipt of adjuvant radiation therapy (RT) in patients with high-risk, early-stage endometrial cancer. METHODS:A retrospective study cohort was selected from 349,404 endometrial carcinoma patients from the National Cancer Database in whom adjuvant RT would be recommended per national guidelines. The study included surgically treated patients with endometrioid endometrial cancer with one of the following criteria: 1) FIGO 2009 stage IB, grade 1/2 disease, age ≥ 60 years; 2) stage IB, grade 3 disease; or 3) stage II disease. Logistic regression analysis was performed to identify factors associated with omission of adjuvant RT. Association between adjuvant RT, covariables, and overall survival (OS) was assessed with multivariable Cox proportional hazards models. RESULTS:19,594 patients were eligible for analysis; 47% did not receive adjuvant RT. Omission of adjuvant RT was more prevalent among African-American, Hispanic, and Asian compared to non-Hispanic white patients (OR 0.79, 95%CI: 0.69-0.91; OR 0.75, 95%CI: 0.64-0.87; OR 0.75, 95%CI: 0.60-0.94, respectively). Lower median household income of patient's area of residence, lack of health insurance, treatment at non-academic hospitals, farther distance to treatment facilities, and residence in metropolitan counties were associated with omission of adjuvant RT. Such omission was independently associated with worse OS (HR1.43, p < 0.001). CONCLUSION:Adjuvant RT is omitted in 47% of patients with early-stage, high-risk endometrial cancer, which is associated with poor access to appropriate, high-quality care and worse outcome.
PMCID:8084986
PMID: 33597092
ISSN: 1095-6859
CID: 5521812
Association of Medicaid expansion with mortality from gynecologic cancers [Letter]
Albright, Benjamin B; Chino, Fumiko; Chino, Junzo P; Havrilesky, Laura J; Aviki, Emeline M; Moss, Haley A
PMCID:8012004
PMID: 33221294
ISSN: 1097-6868
CID: 5521802
Churn and catastrophe: insurance loss and high spending among patients with gynecologic cancer in the United States in the era of the Affordable Care Act [Meeting Abstract]
Albright, Benjamin; Chino, Fumiko; Chino, Junzo; Havrilesky, Laura; Aviki, Emeline; Moss, Haley
ISI:000687070800022
ISSN: 0090-8258
CID: 5522152
A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer [Meeting Abstract]
Lim, Stephanie; Moss, Haley; Havrilesky, Laura; O\Cearbhaill, Roisin; Abu-Rustum, Nadeem; Liang, Maggie; Wright, Jason; Aviki, Emeline
ISI:000687070800132
ISSN: 0090-8258
CID: 5522162
Annual cost of wasted indocyanine green during sentinel lymph node mapping for patients with endometrial cancer [Meeting Abstract]
Marsh, Leah; Salani, Ritu; Wright, Jason; Chen, Ling; Abu-Rustum, Nadeem; Aviki, Emeline
ISI:000687070800158
ISSN: 0090-8258
CID: 5522172
Cancer care affordability: what is our role? [Meeting Abstract]
Aviki, Emeline; Abu-Rustum, Nadeem; Moss, Haley; Chino, Fumiko
ISI:000687070800182
ISSN: 0090-8258
CID: 5522182
Disparities in patient access and disease targets in upfront clinical trials for gynecologic cancers [Meeting Abstract]
Albright, Benjamin; Moss, Haley; Aviki, Emeline; Chino, Fumiko
ISI:000687070800245
ISSN: 0090-8258
CID: 5522192
The impact of race, education, and employment status on cost-coping strategies and patient reported benefit from interventions to mitigate financial toxicity [Meeting Abstract]
Braxton, Kenya; Thom, Bridgette; Brown, Carol L.; Gany, Francesca; Chino, Fumiko; Aviki, Emeline Mariam
ISI:000707130200090
ISSN: 0732-183x
CID: 5522202